Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josephine Blersch

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Methods (San Diego, Calif.)|December 28, 2020
A high-throughput screening platform to identify nanocarriers for efficient delivery of RNA-based therapiesVitor Francisco, Catarina Rebelo, Artur Filipe Rodrigues, et al.
Nanoscale|May 1, 2020
A light-triggerable formulation to control the stability of pro-angiogenic transcription factor hypoxia inducible factor-1α (HIF-1α)Josephine Blersch, Vitor Francisco, Catarina Rebelo, et al.
Angewandte Chemie (International Ed. in English)|November 16, 2019
A Light-Triggerable Nanoparticle Library for the Controlled Release of Non-Coding RNAsJosephine Blersch, Vitor Francisco, Catarina Rebelo, et al.
Nanoscale Horizons|February 12, 2021
Induced pluripotent stem cell-derived vascular networks to screen nano-bio interactionsLuís Estronca, Vitor Francisco, Patrícia Pitrez, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 12, 2017
Antimicrobial peptide-gold nanoscale therapeutic formulation with high skin regenerative potentialMichela Comune, Akhilesh Rai, Kiran K Chereddy, et al.
Plos One|July 1, 2025
Gain efficiency with streamlined and automated data processing: Examples from high-throughput monoclonal antibody productionMalwina Kotowicz, Magdalena Shumanska, Sven Fengler, et al.
Oncoimmunology|September 22, 2025
A versatile silica nanoparticle platform for induction of T cell responses - applied for therapeutic vaccination against HPV16 E6/E7-positive tumors in MHC-humanized miceSebastian Kruse, Lia T Fricke, Samantha Zottnick, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Methods (San Diego, Calif.)|December 28, 2020
A high-throughput screening platform to identify nanocarriers for efficient delivery of RNA-based therapiesVitor Francisco, Catarina Rebelo, Artur Filipe Rodrigues, et al.
Nanoscale|May 1, 2020
A light-triggerable formulation to control the stability of pro-angiogenic transcription factor hypoxia inducible factor-1α (HIF-1α)Josephine Blersch, Vitor Francisco, Catarina Rebelo, et al.
Angewandte Chemie (International Ed. in English)|November 16, 2019
A Light-Triggerable Nanoparticle Library for the Controlled Release of Non-Coding RNAsJosephine Blersch, Vitor Francisco, Catarina Rebelo, et al.
Nanoscale Horizons|February 12, 2021
Induced pluripotent stem cell-derived vascular networks to screen nano-bio interactionsLuís Estronca, Vitor Francisco, Patrícia Pitrez, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 12, 2017
Antimicrobial peptide-gold nanoscale therapeutic formulation with high skin regenerative potentialMichela Comune, Akhilesh Rai, Kiran K Chereddy, et al.
Plos One|July 1, 2025
Gain efficiency with streamlined and automated data processing: Examples from high-throughput monoclonal antibody productionMalwina Kotowicz, Magdalena Shumanska, Sven Fengler, et al.
Oncoimmunology|September 22, 2025
A versatile silica nanoparticle platform for induction of T cell responses - applied for therapeutic vaccination against HPV16 E6/E7-positive tumors in MHC-humanized miceSebastian Kruse, Lia T Fricke, Samantha Zottnick, et al.
Pageof 1